The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy.

Journal: BMC cancer
PMID:

Abstract

BACKGROUND: Viral infections are prevalent in human cancers and they have great diagnostic and theranostic values in clinical practice. Recently, their potential of shaping the tumor immune microenvironment (TIME) has been related to the immunotherapy of human cancers. However, the landscape of viral expressions and immune status in human cancers remains incompletely understood.

Authors

  • Siyuan Chen
    First author: Department of Computer Science, Columbia University in the City of New York, 10027; second, fourth, and sixth authors: Plant Breeding and Genetics Section, School of Integrative Plant Science, Cornell University, Ithaca, NY 14853; third author: Department of Mechanical Engineering, Columbia University; fifth author: Uber AI Labs, San Francisco 94103; seventh author: Plant Pathology and Plant-Microbe Biology Section, School of Integrative Plant Science, Cornell University; and eighth author: Department of Mechanical Engineering and Institute of Data Science, Columbia University.
  • Hongyan Lai
    Department of Medical Oncology, Shanghai Key Laboratory of Medical Epigenetics, Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, Fudan University, 270 Dong An Rd, Shanghai, 200032, China.
  • Jingjing Zhao
    Department of Medical Oncology, Shanghai Key Laboratory of Medical Epigenetics, Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, Fudan University, 270 Dong An Rd, Shanghai, 200032, China.
  • Bing Chen
    Department of Critical Care Medicine, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Yan Li
    Interdisciplinary Research Center for Biology and Chemistry, Liaoning Normal University, Dalian, China.
  • Yuchen Li
    Department of Medical Oncology, Shanghai Key Laboratory of Medical Epigenetics, Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, Fudan University, 270 Dong An Rd, Shanghai, 200032, China.
  • Qin Li
    Department of Spine Surgery, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
  • Qiupeng Zheng
    Department of Medical Oncology, Shanghai Key Laboratory of Medical Epigenetics, Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, Fudan University, 270 Dong An Rd, Shanghai, 200032, China.
  • Shenglin Huang
    Department of Medical Oncology, Shanghai Key Laboratory of Medical Epigenetics, Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, Fudan University, 270 Dong An Rd, Shanghai, 200032, China. slhuang@fudan.edu.cn.
  • Xiaodong Zhu
    Department of Medical Oncology, Shanghai Key Laboratory of Medical Epigenetics, Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, Fudan University, 270 Dong An Rd, Shanghai, 200032, China. xddr001@163.com.